Ccu106 发表于 2025-3-28 16:33:31

http://reply.papertrans.cn/29/2831/283087/283087_41.png

propose 发表于 2025-3-28 19:02:39

Glycopeptides and Antibiotics for Gram-positive Bacterial Infections,ns caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides, lipopeptides, linezolid and quinupristin/dalfopristin in obesity. Specific dosing recom

STAT 发表于 2025-3-29 02:56:14

Azole Antifungal Agents,gement of systemic fungal infections. Their application in the prophylaxis against and treatment of systemic mycoses continues to evolve, with ongoing advancements in drug delivery, efficacy, monitoring and side effect profiling. Pharmacokinetic changes and dose guidance for these agents in the obes

Catheter 发表于 2025-3-29 05:10:52

http://reply.papertrans.cn/29/2831/283087/283087_44.png

Interdict 发表于 2025-3-29 09:27:52

http://reply.papertrans.cn/29/2831/283087/283087_45.png

远地点 发表于 2025-3-29 13:30:14

http://reply.papertrans.cn/29/2831/283087/283087_46.png

尾巴 发表于 2025-3-29 15:35:02

Book 2016ng up-to-date information on antimicrobial dosing in obese patients. Doctors, pharmacists, nurses working in hospital settings, and students of health courses (medical, pharmacy and nursing students) will find this book particularly useful..

蚀刻术 发表于 2025-3-29 20:09:40

http://reply.papertrans.cn/29/2831/283087/283087_48.png

intertwine 发表于 2025-3-30 02:56:53

http://reply.papertrans.cn/29/2831/283087/283087_49.png
页: 1 2 3 4 [5]
查看完整版本: Titlebook: Drug Dosing in Obesity; Volume I: Antimicrob Syed Tabish R. Zaidi,Jason A. Roberts Book 2016 Springer International Publishing Switzerland